XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue Disaggregation
 6 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table presents the Company’s disaggregated revenues by revenue source:

                
   Three Months Ended September 30,   Six Months Ended September 30, 
   2024   2023   2024   2023 
Human Care  $2,957,000   $2,075,000   $5,833,000   $4,825,000 
Animal Care   402,000    489,000    801,000    1,067,000 
Service and Royalty   220,000    167,000    336,000    266,000 
   $3,579,000   $2,731,000   $6,970,000   $6,158,000 

 

The following table shows the Company’s revenues by geographic region:

                  
   Three Months Ended September 30,   Six Months Ended September 30, 
   2024   2023   2024   2023 
United States  $675,000   $590,000   $1,317,000   $1,396,000 
Europe   1,506,000    1,201,000    2,794,000    2,271,000 
Asia   776,000    346,000    1,253,000    1,208,000 
Latin America   465,000    260,000    1,345,000    747,000 
Rest of the World   157,000    334,000    261,000    536,000 
Total  $3,579,000   $2,731,000   $6,970,000   $6,158,000